logo

CSBR

Champions Oncology
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

CSBR fundamentals

Champions Oncology (CSBR) expects to report earnings on Jul 17, 2025, with estimated revenue of 12.01M (YoY -14.22%), and EPS at -0.2 (YoY -2100.00%).
Revenue estimate / YoY
12.01M
-14.22%
EPS estimate / YoY
-0.2
-2100.00%
Report date
Jul 17, 2025
EPS
Revenue

Revenue & Expenses

CSBR has released its 2025 Q3 earnings report, with revenue of 17.04M, reflecting a YoY change of 41.77%, and net profit of 4.50M, showing a YoY change of 277.67%. The Sankey diagram below clearly presents CSBR's revenue sources and cost distribution.

Key Indicators

Champions Oncology (CSBR) key financial stats and ratios, covering profitability, financial health, and leverage.
Champions Oncology (CSBR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Champions Oncology (CSBR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Champions Oncology (CSBR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Champions Oncology (CSBR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Champions Oncology (CSBR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield